Serial 88907295
Live / Registered — Registered (as of 13 Oct 2026)
What this means for you
Registered since 13 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 88907295
- Registration number
- 8497951
- Mark type
- Design / logo
- Filed
- 08 May 2020
- Published for opposition
- 25 Aug 2026
- Registered
- 13 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 13 Oct 2032 (grace period to 13 Apr 2033)
- Attorney of record
- Matthew R. Wilmot
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of kidney diseases and disorders, autoimmune diseases and disorders, inflammatory diseases and disorders, and opthamalogical diseases and disorders; pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis
Owner
- Aurinia Pharmaceuticals Inc., Victoria, BC, CA
- Aurinia Pharmaceuticals Inc., Victoria, BC, CA
- Aurinia Pharmaceuticals Inc., Victoria, BC, CA
Prosecution history
- 13 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Jul 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 22 May 2026 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 22 May 2026 — INQUIRY TO SUSPENSION E-MAILED
- 22 May 2026 — SUSPENSION INQUIRY WRITTEN
- 22 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 21 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 20 Feb 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED